A meta-analysis of our rare variant burden testing and transcriptome analysis revealed that the relationship between reduced function of DNA2 and ACADM and shorter ALS survival was significant after Bonferroni multiple testing correction; and DNA2 was significant in the rare variant analysis in isolation. The gene discussed is ACADM; the disease is amyotrophic lateral sclerosis.